arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Caribou Biosciences, Inc.

CRBU

$1.29 ▼ -0.06 (-4.07%) at close

28 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Caribou Biosciences, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $130.3M

Dividend Yield —

Revenue Growth -43.8% ↘

Op. Margin None

ROIC -20.4% →

FCF / Share $-0.23 ↗

Trailing P/E —

Price / Book 1.4x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

28-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$1.50M

↓ -43.8% —

Net Income Profit after all expenses

$-25.09M

↑ +37.3% —

Operating Margin Operating profit as % of sales

-61.8%

↑ +86.8% —

FCF / Share Free cash flow per share

$-0.23

↑ +26.8% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Revenue Growth YoY (%)	-43.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-647%)	1.9% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-77%)	89.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1022%)	8.6% Fair ↑ Fair Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+7%)	-23.0% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-388%)	-3.1% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-139%)	-41.6% Weak → Weak Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-620%)	-91.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1243%)	-7.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-197%)	-30.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-483%)	-3.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-145%)	616.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+7605%)	-10.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-230%)	31.5% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+293%)	44.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+453%)	-16.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-312%)	184.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2200%)	68.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+750%)	160.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1901%)	232.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2800%)	-82.6% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1132%)	—	—	—	—	—	—	—
EPS Growth YoY (%)	58.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	39.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	28.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	21.1% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-38.1% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	6.5% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	2.5% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-216.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	12.5% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	11.1% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	72.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-9.1% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	N/M	4.3% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	37.3% Excellent ↑ Excellent Improving Year-over-year change in net income	37.3% Excellent ↑ Excellent Improving Year-over-year change in net income	25.4% Excellent ↑ Excellent Improving Year-over-year change in net income	3.0% Caution ↑ Caution Improving Year-over-year change in net income	3.0% Caution ↑ Caution Improving Year-over-year change in net income	3.0% Caution ↑ Caution Improving Year-over-year change in net income	-2.9% Weak ↑ Weak Improving Year-over-year change in net income	-47.0% Weak ↓ Weak Declining Year-over-year change in net income	-47.0% Weak ↓ Weak Declining Year-over-year change in net income	-47.0% Weak ↓ Weak Declining Year-over-year change in net income	-27.8% Weak ↑ Weak Improving Year-over-year change in net income	-46.9% Weak → Weak Stable Year-over-year change in net income	-46.9% Weak → Weak Stable Year-over-year change in net income	-46.9% Weak → Weak Stable Year-over-year change in net income	-46.1% Weak → Weak Stable Year-over-year change in net income	-45.1% Weak ↓ Weak Declining Year-over-year change in net income	-45.1% Weak ↓ Weak Declining Year-over-year change in net income	-45.1% Weak ↓ Weak Declining Year-over-year change in net income	-25.7% Weak ↑ Weak Improving Year-over-year change in net income	-34.3% Weak Weak Year-over-year change in net income	-34.3% Weak Weak Year-over-year change in net income	—	—	—	—	—	—	—
FCF Growth YoY (%)	26.8% Excellent Excellent Year-over-year change in free cash flow	30.7% Excellent Excellent Year-over-year change in free cash flow	—	—	—	5.8% Fair Fair Year-over-year change in free cash flow	—	—	—	11.6% Fair ↓ Fair Declining Year-over-year change in free cash flow	—	-2.7% Weak Weak Year-over-year change in free cash flow	28.4% Excellent Excellent Year-over-year change in free cash flow	—	—	-12.5% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-26.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-11.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	2.2% Caution ↑ Caution Improving Compound annual revenue growth over 3 years	-12.7% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-14.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-4.1% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-6.7% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-20.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	32.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	15.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	53.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	170.3% Excellent Excellent Compound annual revenue growth over 3 years	-23.8% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	0.3% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	8.6% Good ↑ Good Improving Compound annual revenue growth over 5 years	32.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	12.9% Excellent Excellent Compound annual revenue growth over 5 years	-20.7% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	-61.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-512%)	—	—	—	—	—	—	—	-468.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3221%)	—	—	—	—	-26.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-277%)	—	—	—
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-1.8% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	21.8% Fair ↑ Fair Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	2.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	-118.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1088%)	—	—	—	—	-455.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3895%)	—	—	-330.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2857%)	—	—	—	—	-115.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1063%)	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	-141.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-472.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	-399.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.91x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.08x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.63x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	0.94x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.20x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.63x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.07x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.24x Good → Good Stable Free cash flow relative to reported net income Optimal: > 1x	1.28x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.17x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	1.19x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.21x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	—	-1.54x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.55x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	-20.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.4% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-16.4% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-22.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	33.5% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	29.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	50.8% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	75.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	59.9% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-17.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-17.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-15.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-8.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-9.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-8.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-4.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-10.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-42.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—
Return on Common Equity (%) (%)	-25.6% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-270%)	-24.6% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-264%)	-21.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-245%)	-28.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-288%)	-24.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-260%)	-18.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-223%)	-14.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-194%)	-14.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-198%)	-13.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-189%)	-12.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-180%)	-9.4% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-162%)	-7.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-147%)	-10.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-169%)	-10.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-167%)	-9.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-160%)	-5.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-139%)	-5.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-137%)	-5.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-134%)	-4.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-132%)	-3.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-122%)	27.6% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+84%)	36.9% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+146%)	62.7% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+318%)	87.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+483%)	267.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1683%)	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-7982.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-3293.75x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-2535.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1371.50x Weak Weak Operating income divided by interest expense Optimal: > 5x	-451.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$-26.19M	$-12.06M	$-12.36M	$-11.14M	$-25.20M	$-29.42M	$-16.29M	$-31.97M	$-37.87M	$-49.40M	$-51.16M	$-104.06M	$-66.19M	$-52.74M	$-58.34M	$-82.08M	$-112.15M	$-147.63M	$-240.42M	$-435.31M	$-129.52M	$-145.92M	$-15.95M	$-24.55M	$-33.13M	—	$-41.07M	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Revenue per Share (USD)	$0.01	$0.03	—	$0.02	$0.03	$0.03	—	$0.02	$0.04	$0.03	—	$0.28	$0.06	$0.06	—	$0.05	$0.07	—	—	$0.09	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.24	$-0.26	$-0.28	$-0.30	$-0.58	$-0.43	$-0.39	$-0.38	$-0.42	$-0.46	$-0.40	$-0.12	$-0.48	$-0.46	$-0.45	$-0.44	$-0.44	—	$0.09	$-0.46	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.23	$-0.28	—	$-0.27	$-0.31	$-0.41	—	—	—	$-0.43	—	$-0.40	$-0.29	$-0.49	—	$-0.39	$-0.40	—	—	$-0.35	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.93	$1.05	$1.28	$1.52	$1.79	$2.34	$2.74	$3.11	$3.44	$3.80	$4.17	$4.75	$4.39	$4.54	$4.93	$5.32	$5.73	$6.13	$6.44	$8.81	$-4.21	—	$-2.41	—	—	—	—	—
Tangible Book Value per Share (USD)	$0.93	$1.05	$1.28	$1.52	$1.79	$2.34	$2.74	$3.11	$3.44	$3.80	$4.17	$4.75	$4.39	$4.54	$4.93	$5.32	$5.73	$6.13	$6.44	$8.81	$-4.21	—	$-2.41	—	—	—	—	—
Basic Weighted Avg Shares (shares)	100.99M	95.86M	—	93.29M	93.03M	92.68M	—	90.46M	90.34M	89.30M	—	83.78M	61.42M	61.19M	—	60.89M	60.76M	—	—	45.89M	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$98.62M	$102.71M	$119.82M	$127.45M	—	$188.83M	$188.73M	$205.27M	$239.94M	$275.49M	$310.54M	—	—	$212.39M	$232.12M	—	—	$341.34M	$365.36M	—	$116.96M	—	$11.92M	—	—	—	—	—
Total Equity (USD)	$98.10M	$102.02M	$122.17M	$141.84M	$166.13M	$217.22M	$252.95M	$281.20M	$310.46M	$343.29M	$368.40M	$398.27M	$269.46M	$278.27M	$300.87M	$324.11M	$347.89M	$371.80M	$387.82M	$404.40M	$-47.69M	$-35.69M	$-23.44M	$-11.21M	$-3.67M	$-2.10M	$7.46M	$29.95M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	$1.50M	$2.40M	$3.94M	$2.20M	$2.67M	$2.35M	$2.08M	$2.02M	$3.46M	$2.43M	$3.56M	$23.66M	$3.75M	$3.50M	$3.69M	$3.30M	$4.19M	$2.66M	$2.56M	$3.98M	$1.48M	$1.59M	$984.00K	$1.20M	$8.48M	—	—	—
Depreciation Expense (USD)	$625.00K	$649.00K	$682.00K	$631.00K	$1.17M	$1.17M	$1.18M	—	—	$710.00K	$740.00K	$1.58M	$617.00K	$589.00K	$506.00K	$450.00K	$358.00K	$308.00K	$273.00K	$260.00K	—	$221.00K	$220.00K	$226.00K	—	—	—	—
Net Income, GAAP (USD)	$-25.09M	$-25.09M	$-26.49M	$-39.99M	$-39.99M	$-39.99M	$-35.49M	$-41.23M	$-41.23M	$-41.23M	$-34.51M	$-28.04M	$-28.04M	$-28.04M	$-26.99M	$-19.09M	$-19.09M	$-19.09M	$-18.48M	$-13.16M	$-13.16M	$-13.16M	$-14.70M	$-9.80M	$-9.80M	—	—	—
Operating Cash Flow (USD)	$-22.79M	$-26.98M	$-20.82M	$-25.18M	$-28.26M	$-36.73M	$-35.47M	—	—	$-37.20M	$-21.38M	$-28.79M	$-15.19M	$-27.94M	$-25.04M	$-22.38M	$-21.87M	$-21.67M	$-21.39M	$-14.97M	—	$20.31M	$-8.08M	$-8.69M	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 8 years · 28 quarters

Caribou Biosciences, Inc.

Analytical Summary

28-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CRBU with peers